Dyne Therapeutics Stock Forecast
NASDAQ: DYNHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
DYN analyst consensus
Consensus (17 analysts)
strong_buy
Avg. price target
$36.00+125.42%
- Strong buy 3
- Buy 13
- Hold 0
- Sell 0
- Strong sell 1
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
According to 17 Wall Street analysts covering Dyne Therapeutics (2026-10-07), 16 rate the stock a buy or strong buy, 0 rate it a hold and 1 rate it a sell or strong sell, for a consensus rating of "strong_buy". The average 12-month price target is $36.00, with a high estimate of $50.00 and a low estimate of $10.00. The average target implies upside of 125.4% from the current price of $15.97.
The spread between the highest and lowest targets is 400.0%, a wide range that reflects significant disagreement among analysts. Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for DYN.
Summary generated from market data by MetaCap's automated system. Methodology
Rating distribution
| Rating | Analysts | Share |
|---|---|---|
| Strong buy | 3 | 18% |
| Buy | 13 | 76% |
| Hold | 0 | 0% |
| Sell | 0 | 0% |
| Strong sell | 1 | 6% |
Ratings as of 2026-10-07.
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $10.00 | -37.38% |
| Average target | $36.00 | +125.42% |
| High target | $50.00 | +213.09% |